Literature DB >> 23393716

Ankylosing spondylitis: field in progress.

Gleb Slobodin1, Itzhak Rosner, Doron Rimar, Nina Boulman, Michael Rozenbaum, Majed Odeh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23393716

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  8 in total

1.  Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastic osteogenesis and its molecular mechanism.

Authors:  Chunrong Jia; Hongxiao Liu; Min Li; Zhikui Wu; Xinghua Feng
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system.

Authors:  A Śliwczyński; F Raciborski; A Kłak; M Brzozowska; T Czeleko; B Kwiatkowska; T Jędrzejczyk; M Marczak
Journal:  Rheumatol Int       Date:  2015-03-13       Impact factor: 2.631

3.  Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis.

Authors:  Huifang Guo; Ming Zheng; Kui Zhang; Fengfan Yang; Xin Zhang; Qing Han; Zhi-Nan Chen; Ping Zhu
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

4.  Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis.

Authors:  Ai Li; Yuan Tao; Dexiao Kong; Ni Zhang; Yongjing Wang; Zhilun Wang; Yingxue Wang; Juandong Wang; Juan Xiao; Yang Jiang; Xiaoli Liu; Chengyun Zheng
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

5.  Pathogenic variants screening in seventeen candidate genes on 2p15 for association with ankylosing spondylitis in a Han Chinese population.

Authors:  Mengmeng Wang; Lihong Xin; Guoqi Cai; Xu Zhang; Xiao Yang; Xiaona Li; Qing Xia; Li Wang; Shengqian Xu; Jianhua Xu; Zongwen Shuai; Changhai Ding; Faming Pan
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

6.  Efficacy of etoricoxib for ankylosing spondylitis: A protocol for systematic review of randomized controlled trial.

Authors:  Hua-Yu Tang; Yu Zhao; Yu-Zhi Li; Tian-Shu Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

7.  Anti-inflammatory activity of extracts of Bushen-Qiangdu-Zhilv decoction, a Chinese medicinal formula, in M1-polarized RAW264.7.

Authors:  Run-Yue Huang; Jie-Hua Lin; Xiao-Hong He; Xiong Li; Chuan-Li Lu; Ying-Yan Zhou; Jun Cai; Yi-Ting He
Journal:  BMC Complement Altern Med       Date:  2014-07-28       Impact factor: 3.659

8.  Overexpression of miR-31 in Peripheral Blood Mononuclear Cells (PBMC) from Patients with Ankylosing Spondylitis.

Authors:  Mengmeng Wang; Li Wang; Xu Zhang; Xiao Yang; Xiaona Li; Qing Xia; Mengya Chen; Renfang Han; Rui Liu; Shengqian Xu; Faming Pan
Journal:  Med Sci Monit       Date:  2017-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.